Related content

Hypoxia induces resistance to ALK inhibitors in the H3122 non-small cell lung cancer cell line with an ALK rearrangement via epithelial-mesenchymal transition

By                          

International Journal of Oncology, Vol. 45, Iss. 4, 2014-01 ,pp. : 1430-1436

Spandidos Publications

Access to resources Recommend Favorite

Ask the Experts: Managing non-small-cell lung cancer with acquired resistance to EGF receptor and ALK inhibitors

By Lee Siow-Ming   King Judy  

Lung Cancer Management, Vol. 2, Iss. 1, 2013-02 ,pp. : 23-26

Future Medicine

Access to resources Recommend Favorite

Molecular-targeted therapy for elderly patients with advanced non-small cell lung cancer (Review)

By                  

Oncology Letters, Vol. 11, Iss. 1, 2016-01 ,pp. : 3-8

Spandidos Publications

Access to resources Recommend Favorite

Phase II study of liarozole in advanced non-small cell lung cancer

By O'Byrne K.J.   Han C.   Mitchell K.   Lane D.   Carmichael J.   Harris A.L.   Talbot D.C.  

European Journal of Cancer, Vol. 34, Iss. 9, 1998-08 ,pp. : 1463-1466

Elsevier

Access to resources Recommend Favorite

Gemcitabine plus vinorelbine for the treatment of advanced non-small cell lung cancer

By Baron F.   Cueva J.   Grana B.   Curiel T.   Leon L.   Vazquez F.   Candamio S.   Lopez R.  

European Journal of Cancer, Vol. 37, Iss. 11, 2001-07 ,pp. : 1381-1384

Elsevier

Access to resources Recommend Favorite